MNBTD
IOVA icon

Moody National Bank Trust Division’s Iovance Biotherapeutics IOVA Stock Holding History

Moody National Bank Trust Division’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-551
Closed -$5K – 661
2019
Q1 		$5K Buy
+551
New +$5.35K ﹤0.01% 914

Other funds holding IOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Moody National Bank Trust Division's IOVA Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Iovance Biotherapeutics (IOVA) in Q2 2019, closing a stake of 551 shares — an estimated $5K sold.

Moody National Bank Trust Division first reported a position in IOVA in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 167 funds tracked by Wall St. Rank hold IOVA as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Iovance Biotherapeutics position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 551 Iovance Biotherapeutics shares in Q2 2019, an estimated $5K.
  • Moody National Bank Trust Division first reported a position in Iovance Biotherapeutics in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Iovance Biotherapeutics position peaked at $5K in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.